Citation Impact
Citing Papers
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β
2001
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis
2000
Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential
1999
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Biological Effects of C-type Natriuretic Peptide in Human Myofibroblastic Hepatic Stellate Cells
1999
PDGF and signal transduction in hepatic stellate cells
2002
Liver fibrosis
2005 Standout
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
2007
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
2005
Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts
2011
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
2010 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Mechanisms of hepatic stellate cell activation
2017 Standout
Emerging insights into Transforming growth factor Smad signal in hepatic fibrogenesis
2007
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Hepatic Stellate Cells and Liver Fibrosis
2013
Human schistosomiasis
2006 Standout
Liver fibrosis – from bench to bedside
2003 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells
2003
Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1
1998
Functions of the Fibrinolytic System in Human Ito Cells and Its Control by Basic Fibroblast and Platelet–Derived Growth Factor
1999
NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia
2004
Glycopeptide-preferring Polypeptide GalNAc Transferase 10 (ppGalNAc T10), Involved in Mucin-type O-Glycosylation, Has a Unique GalNAc-O-Ser/Thr-binding Site in Its Catalytic Domain Not Found in ppGalNAc T1 or T2
2009 StandoutNobel
Albumin Modified With Mannose 6–Phosphate: A Potential Carrier for Selective Delivery of Antifibrotic Drugs to Rat and Human Hepatic Stellate Cells
1999
PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation
2004
Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate
2002
PDGF-Mediated Chemoattraction of Hepatic Stellate Cells by Bile Duct Segments in Cholestatic Liver Injury
2000
Drug-Induced Hepatotoxicity
2003 Standout
Systemic sclerosis
2017 Standout
Origins and functions of liver myofibroblasts
2013
Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking☆
2004
Hepatotoxicity of herbal remedies.
1989
Down‐regulation of cyclin E1 expression by microrna‐195 accounts for interferon‐β‐induced inhibition of hepatic stellate cell proliferation
2010
Hepatic stellate cells and the regulation of liver inflammation
1999
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Hepatitis C and liver fibrosis
2003
Stromal myofibroblasts are drivers of invasive cancer growth
2008
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Mechanisms controlling early development of the liver
2002
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia
1999
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Regulation of PDGF and its receptors in fibrotic diseases
2004
Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathways
2009
Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice
2003
Genomic and functional characterization of stellate cells isolated from human cirrhotic livers
2005
DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells
2001
Severe Hepatic Fibrosis in Schistosoma mansoni Infection Is Controlled by a Major Locus That Is Closely Linked to the Interferon-γ Receptor Gene
1999
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
2005
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension
2002
Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosis
1999
Polycystic Ovary Syndrome
1995 Standout
Thrombin inhibits migration of human hepatic myofibroblasts
2007
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
2011
Upregulated Expression of Fibroblast Growth Factor (FGF) Receptors by Transforming Growth Factor-β1 (TGF-β1) Mediates Enhanced Mitogenic Responses to FGFs in Cultured Human Lung Fibroblasts
1998
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation
2003
Diabetes and Atherosclerosis
2002 Standout
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
2007
Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells
1998
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
2001 Standout
Autocrine release of TGF‐β by portal fibroblasts regulates cell growth
2004
Mechanisms and Therapy of Hepatic Fibrosis: Report of the Aasld Single Topic Basic Research Conference
2000
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis
1997
Hepatocyte Transplantation Activates Hepatic Stellate Cells With Beneficial Modulation of Cell Engraftment in the Rat *
2005
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells
1996
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads
2006
Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling
2001
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in Mice
2004
Polycystic Ovary Syndrome
2005 Standout
Avidin–Biotin ELISA for Measurement of Prothrombin in Human Plasma
2001
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Treatment of pruritus of primary biliary cirrhosis with rifampin
1991
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.
1988
Wound–Induced Migration of Rat Hepatic Stellate Cells Is Modulated by Endothelin–1 Through Rho–Kinase–Mediated Alterations in the Acto–Myosin Cytoskeleton
2001
Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells
1999
Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries
2007
Idiopathic Pulmonary Fibrosis
2001 Standout
Mechanisms of Myofibroblast Activity and Phenotypic Modulation
1999
Signal transduction in hepatic stellate cells
1998
Effect of antioxidants, resveratrol, quercetin, and N -acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells
1998
CELLUAR PATHOPHYSIOLOGY OF PORTAL HYPERTENSION AND PROSPECTS FOR MANAGEMENT WITH GENE THERAPY
2001
Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
2000
Transforming growth factor‐β1 induces activation of Ras, Raf‐1, MEK and MAPK in rat hepatic stellate cells
1997
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
2015
Vascular mediators in the injured liver
2003
Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis
2003
Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts
2015
Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.
1996
Hepatocyte growth factor and epidermal growth factor activity during later stages of rat liver regeneration upon interferon α-2b influence
2017
In Vitro Migratory Potential of Rat Quiescent Hepatic Stellate Cells and Its Augmentation by Cell Activation
1999
The formation of capsule and septum in human hepatocellular carcinoma
2001
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Neutrophil–Kupffer-cell interaction in host defenses to systemic infections
1998
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Chronic liver injury, TGF-β, and cancer
2001
Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chonic HCV infection?
1998
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis
2001
Molecular regulation of hepatic fibrogenesis
1998
Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis
2002
Free radicals, antioxidant enzymes, and carcinogenesis
1990
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by In Vivo liver injury in the rat
1999
Spironolactone as a single agent for long‐term therapy of hirsute patients
2000
Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells
1994
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Increased Endothelin-1 in Bleomycin-induced Pulmonary Fibrosis and the Effect of an Endothelin Receptor Antagonist
1997
Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization.
1992
DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells
2001
Primary Biliary Cirrhosis
1987 Standout
Myofibroblasts. I. Paracrine cells important in health and disease
1999
Liver nbsp fibrosis signals leading to the amplification of the fibrogenic hepatic stellate cell
2003
Reactive oxygen species in cell signaling
2000 Standout
A correlation between hydroxyl radical generation and ethanol oxidation by liver, lung and kidney microsomes
1982
Pulmonary Arterial Hypertension
2006
Interferon Alfa Down–Regulates Collagen Gene Transcription and Suppresses Experimental Hepatic Fibrosis in Mice
2003
A chemical-modification approach to the olfactory code. Studies with a thiol-specific reagent
1978
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning
2003
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
The Cellular Pathogenesis of Portal Hypertension: Stellate Cell Contractility, Endothelin, and Nitric Oxide
1997
Reversal of Liver Fibrosis and Cirrhosis — An Emerging Reality
2004
Human Hepatic Stellate Cells Show Features of Antigen–Presenting Cells and Stimulate Lymphocyte Proliferation
2003
Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
1997 Standout
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells
2013
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
2005
Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis
1998
Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level.
1990 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Role of Transcriptional Factors in Stellate Cell Activation
1999
Confocal microscopy immunofluorescence localization of desmin and other intermediate filament proteins in fetal rat livers
1993
HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets
2004
11 Treatment of hirsutism and acne with cyproterone acetate
1986
Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP
1999
Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose
1982 StandoutNature
Transforming growth factor β and cancer
1995
Works of Philippe Mavier being referenced
[Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases].
1993
Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats
2011
Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2
2002
Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions
1999
Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells
1997
Immunolocalization of heparinbinding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF‐2 in carbon tetrachloride‐induced fibrosis
1993
In vitro toxicity of hydrogen peroxide against normal vs. tumor rat hepatocytes: Role of catalase and of the glutathione redox cycle
1988
Mouse hepatic endothelial cells in culture secrete a growth inhibitor for hepatic lipocytes and Balb/c 3T3 fibroblasts
1989
Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.
1995
Fibroblast growth factor 2 and transforming growth factor β1 interactions in human liver myofibroblasts
1995
Platelet-derived Growth Factor-BB and Thrombin Generate Positive and Negative Signals for Human Hepatic Stellate Cell Proliferation
1998
Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.
1996
Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice
2009
Expression and Role of Gas6 Protein and of Its Receptor Axl in Hepatic Regeneration From Oval Cells in the Rat
2005
Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat
2008
Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells
2006
Demonstration of a basic fibroblast growth factor-like molecule in mouse hepatic endothelial cells
1989
In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: Evidence for a proteinase-mediated mechanism
1988
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
1995
Mitogenic effect of transforming growth factor-β1 on human ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factor
1993
Induction of Hepatic Microsomal Enzymes after Brief Administration of Rifampicin in Man
1977
Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study
1998
Coagulation Assays as Diagnostic Markers of Hepatocellular Carcinoma
1988
Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor.
1993
Androgen metabolism in hirsute patients treated with cyproterone acetate
1984
Antiproliferative Effects of ET-1 in Human Liver Ito Cells
1995
Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver
1995
Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
1984
Chronic Ethanol Administration Induces a Form of Cytochrome P‐450 with Specific Spectral and Catalytic Properties
1977
Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice
2011
354 Growth arrest-specific protein 6 (GAS6) promotes liver tissue repair after an acute toxic injury
2006
Adenylate Cyclase from Rat‐Liver Plasma Membrane: Inhibition by Mersalyl and Other Mercurial Derivatives
1975